Report Detail
Global Endometriosis Therapies Market Insights, Forecast to 2025
- RnM3447588 |
- 22 May, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Chemical & Material
Therapies used to treat endometriosis include: Hormonal contraceptives. Birth control pills, patches and vaginal rings help control the hormones responsible for the buildup of endometrialtissue each month
Global Endometriosis Therapies market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Endometriosis Therapies.
This report researches the worldwide Endometriosis Therapies market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Endometriosis Therapies breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
The following manufacturers are covered in this report:
AbbVie
Eli Lilly
AstraZeneca
Bayer
Astellas Pharma
Meditrina Pharmaceuticals
Pfizer
Neurocrine Biosciences
Takeda Pharmaceutical
Endometriosis Therapies Breakdown Data by Type
Hormonal Contraceptives
Gonadotropin-releasing Hormone (Gn-RH) Agonists
Progestin Therapy
Aromatase Inhibitors
Endometriosis Therapies Breakdown Data by Application
Hospital
Clinic
Other
Endometriosis Therapies Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions
Endometriosis Therapies Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives are:
To analyze and research the global Endometriosis Therapies capacity, production, value, consumption, status and forecast;
To focus on the key Endometriosis Therapies manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Endometriosis Therapies :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
Global Endometriosis Therapies Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications
1 Study Coverage
- 1.1 Endometriosis Therapies Product
- 1.2 Key Market Segments in This Study
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Endometriosis Therapies Market Size Growth Rate by Type
- 1.4.2 Hormonal Contraceptives
- 1.4.3 Gonadotropin-releasing Hormone (Gn-RH) Agonists
- 1.4.4 Progestin Therapy
- 1.4.5 Aromatase Inhibitors
- 1.5 Market by Application
- 1.5.1 Global Endometriosis Therapies Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Endometriosis Therapies Production
- 2.1.1 Global Endometriosis Therapies Revenue 2014-2025
- 2.1.2 Global Endometriosis Therapies Production 2014-2025
- 2.1.3 Global Endometriosis Therapies Capacity 2014-2025
- 2.1.4 Global Endometriosis Therapies Marketing Pricing and Trends
- 2.2 Endometriosis Therapies Growth Rate (CAGR) 2019-2025
- 2.3 Analysis of Competitive Landscape
- 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 2.3.2 Key Endometriosis Therapies Manufacturers
- 2.4 Market Drivers, Trends and Issues
- 2.5 Macroscopic Indicator
- 2.5.1 GDP for Major Regions
- 2.5.2 Price of Raw Materials in Dollars: Evolution
3 Market Size by Manufacturers
- 3.1 Endometriosis Therapies Production by Manufacturers
- 3.1.1 Endometriosis Therapies Production by Manufacturers
- 3.1.2 Endometriosis Therapies Production Market Share by Manufacturers
- 3.2 Endometriosis Therapies Revenue by Manufacturers
- 3.2.1 Endometriosis Therapies Revenue by Manufacturers (2014-2019)
- 3.2.2 Endometriosis Therapies Revenue Share by Manufacturers (2014-2019)
- 3.3 Endometriosis Therapies Price by Manufacturers
- 3.4 Mergers & Acquisitions, Expansion Plans
4 Endometriosis Therapies Production by Regions
- 4.1 Global Endometriosis Therapies Production by Regions
- 4.1.1 Global Endometriosis Therapies Production Market Share by Regions
- 4.1.2 Global Endometriosis Therapies Revenue Market Share by Regions
- 4.2 United States
- 4.2.1 United States Endometriosis Therapies Production
- 4.2.2 United States Endometriosis Therapies Revenue
- 4.2.3 Key Players in United States
- 4.2.4 United States Endometriosis Therapies Import & Export
- 4.3 Europe
- 4.3.1 Europe Endometriosis Therapies Production
- 4.3.2 Europe Endometriosis Therapies Revenue
- 4.3.3 Key Players in Europe
- 4.3.4 Europe Endometriosis Therapies Import & Export
- 4.4 China
- 4.4.1 China Endometriosis Therapies Production
- 4.4.2 China Endometriosis Therapies Revenue
- 4.4.3 Key Players in China
- 4.4.4 China Endometriosis Therapies Import & Export
- 4.5 Japan
- 4.5.1 Japan Endometriosis Therapies Production
- 4.5.2 Japan Endometriosis Therapies Revenue
- 4.5.3 Key Players in Japan
- 4.5.4 Japan Endometriosis Therapies Import & Export
- 4.6 Other Regions
- 4.6.1 South Korea
- 4.6.2 India
- 4.6.3 Southeast Asia
5 Endometriosis Therapies Consumption by Regions
- 5.1 Global Endometriosis Therapies Consumption by Regions
- 5.1.1 Global Endometriosis Therapies Consumption by Regions
- 5.1.2 Global Endometriosis Therapies Consumption Market Share by Regions
- 5.2 North America
- 5.2.1 North America Endometriosis Therapies Consumption by Application
- 5.2.2 North America Endometriosis Therapies Consumption by Countries
- 5.2.3 United States
- 5.2.4 Canada
- 5.2.5 Mexico
- 5.3 Europe
- 5.3.1 Europe Endometriosis Therapies Consumption by Application
- 5.3.2 Europe Endometriosis Therapies Consumption by Countries
- 5.3.3 Germany
- 5.3.4 France
- 5.3.5 UK
- 5.3.6 Italy
- 5.3.7 Russia
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Endometriosis Therapies Consumption by Application
- 5.4.2 Asia Pacific Endometriosis Therapies Consumption by Countries
- 5.4.3 China
- 5.4.4 Japan
- 5.4.5 South Korea
- 5.4.6 India
- 5.4.7 Australia
- 5.4.8 Indonesia
- 5.4.9 Thailand
- 5.4.10 Malaysia
- 5.4.11 Philippines
- 5.4.12 Vietnam
- 5.5 Central & South America
- 5.5.1 Central & South America Endometriosis Therapies Consumption by Application
- 5.5.2 Central & South America Endometriosis Therapies Consumption by Countries
- 5.5.3 Brazil
- 5.6 Middle East and Africa
- 5.6.1 Middle East and Africa Endometriosis Therapies Consumption by Application
- 5.6.2 Middle East and Africa Endometriosis Therapies Consumption by Countries
- 5.6.3 Turkey
- 5.6.4 GCC Countries
- 5.6.5 Egypt
- 5.6.6 South Africa
6 Market Size by Type
- 6.1 Global Endometriosis Therapies Breakdown Dada by Type
- 6.2 Global Endometriosis Therapies Revenue by Type
- 6.3 Endometriosis Therapies Price by Type
7 Market Size by Application
- 7.1 Overview
- 7.2 Global Endometriosis Therapies Breakdown Dada by Application
- 7.2.1 Global Endometriosis Therapies Consumption by Application
- 7.2.2 Global Endometriosis Therapies Consumption Market Share by Application (2014-2019)
8 Manufacturers Profiles
- 8.1 AbbVie
- 8.1.1 AbbVie Company Details
- 8.1.2 Company Description
- 8.1.3 Capacity, Production and Value of Endometriosis Therapies
- 8.1.4 Endometriosis Therapies Product Description
- 8.1.5 SWOT Analysis
- 8.2 Eli Lilly
- 8.2.1 Eli Lilly Company Details
- 8.2.2 Company Description
- 8.2.3 Capacity, Production and Value of Endometriosis Therapies
- 8.2.4 Endometriosis Therapies Product Description
- 8.2.5 SWOT Analysis
- 8.3 AstraZeneca
- 8.3.1 AstraZeneca Company Details
- 8.3.2 Company Description
- 8.3.3 Capacity, Production and Value of Endometriosis Therapies
- 8.3.4 Endometriosis Therapies Product Description
- 8.3.5 SWOT Analysis
- 8.4 Bayer
- 8.4.1 Bayer Company Details
- 8.4.2 Company Description
- 8.4.3 Capacity, Production and Value of Endometriosis Therapies
- 8.4.4 Endometriosis Therapies Product Description
- 8.4.5 SWOT Analysis
- 8.5 Astellas Pharma
- 8.5.1 Astellas Pharma Company Details
- 8.5.2 Company Description
- 8.5.3 Capacity, Production and Value of Endometriosis Therapies
- 8.5.4 Endometriosis Therapies Product Description
- 8.5.5 SWOT Analysis
- 8.6 Meditrina Pharmaceuticals
- 8.6.1 Meditrina Pharmaceuticals Company Details
- 8.6.2 Company Description
- 8.6.3 Capacity, Production and Value of Endometriosis Therapies
- 8.6.4 Endometriosis Therapies Product Description
- 8.6.5 SWOT Analysis
- 8.7 Pfizer
- 8.7.1 Pfizer Company Details
- 8.7.2 Company Description
- 8.7.3 Capacity, Production and Value of Endometriosis Therapies
- 8.7.4 Endometriosis Therapies Product Description
- 8.7.5 SWOT Analysis
- 8.8 Neurocrine Biosciences
- 8.8.1 Neurocrine Biosciences Company Details
- 8.8.2 Company Description
- 8.8.3 Capacity, Production and Value of Endometriosis Therapies
- 8.8.4 Endometriosis Therapies Product Description
- 8.8.5 SWOT Analysis
- 8.9 Takeda Pharmaceutical
- 8.9.1 Takeda Pharmaceutical Company Details
- 8.9.2 Company Description
- 8.9.3 Capacity, Production and Value of Endometriosis Therapies
- 8.9.4 Endometriosis Therapies Product Description
- 8.9.5 SWOT Analysis
9 Production Forecasts
- 9.1 Endometriosis Therapies Production and Revenue Forecast
- 9.1.1 Global Endometriosis Therapies Production Forecast 2019-2025
- 9.1.2 Global Endometriosis Therapies Revenue Forecast 2019-2025
- 9.2 Endometriosis Therapies Production and Revenue Forecast by Regions
- 9.2.1 Global Endometriosis Therapies Revenue Forecast by Regions
- 9.2.2 Global Endometriosis Therapies Production Forecast by Regions
- 9.3 Endometriosis Therapies Key Producers Forecast
- 9.3.1 United States
- 9.3.2 Europe
- 9.3.3 China
- 9.3.4 Japan
- 9.4 Forecast by Type
- 9.4.1 Global Endometriosis Therapies Production Forecast by Type
- 9.4.2 Global Endometriosis Therapies Revenue Forecast by Type
10 Consumption Forecast
- 10.1 Consumption Forecast by Application
- 10.2 Endometriosis Therapies Consumption Forecast by Regions
- 10.3 North America Market Consumption Forecast
- 10.3.1 North America Endometriosis Therapies Consumption Forecast by Countries 2019-2025
- 10.3.2 United States
- 10.3.3 Canada
- 10.3.4 Mexico
- 10.4 Europe Market Consumption Forecast
- 10.4.1 Europe Endometriosis Therapies Consumption Forecast by Countries 2019-2025
- 10.4.2 Germany
- 10.4.3 France
- 10.4.4 UK
- 10.4.5 Italy
- 10.4.6 Russia
- 10.5 Asia Pacific Market Consumption Forecast
- 10.5.1 Asia Pacific Endometriosis Therapies Consumption Forecast by Countries 2019-2025
- 10.5.2 China
- 10.5.3 Japan
- 10.5.4 Korea
- 10.5.5 India
- 10.5.6 Australia
- 10.5.7 Indonesia
- 10.5.8 Thailand
- 10.5.9 Malaysia
- 10.5.10 Philippines
- 10.5.11 Vietnam
- 10.6 Central & South America Market Consumption Forecast
- 10.6.1 Central & South America Endometriosis Therapies Consumption Forecast by Country 2019-2025
- 10.6.2 Brazil
- 10.7 Middle East and Africa Market Consumption Forecast
- 10.7.1 Middle East and Africa Endometriosis Therapies Consumption Forecast by Countries 2019-2025
- 10.7.2 Middle East and Africa
- 10.7.3 Turkey
- 10.7.4 GCC Countries
- 10.7.5 Egypt
- 10.7.6 South Africa
11 Upstream, Industry Chain and Downstream Customers Analysis
- 11.1 Analysis of Endometriosis Therapies Upstream Market
- 11.1.1 Endometriosis Therapies Key Raw Material
- 11.1.2 Typical Suppliers of Key Endometriosis Therapies Raw Material
- 11.1.3 Endometriosis Therapies Raw Material Market Concentration Rate
- 11.2 Endometriosis Therapies Industry Chain Analysis
- 11.3 Marketing & Distribution
- 11.4 Endometriosis Therapies Distributors
- 11.5 Endometriosis Therapies Customers
12 Opportunities & Challenges, Threat and Affecting Factors
- 12.1 Market Opportunities
- 12.2 Market Challenges
- 12.3 Porter's Five Forces Analysis
13 Key Findings
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Endometriosis Therapies . Industry analysis & Market Report on Endometriosis Therapies is a syndicated market report, published as Global Endometriosis Therapies Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Endometriosis Therapies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
